Baclofen Withdrawal

27 Oct
October 27, 2016

Baclofen WithdrawalDefinition: A dysfunctional condition in which removal of baclofen, an inhibitory neurotransmitter, from the central nervous system (CNS) causes CNS excitation.

Pathophysiology of Baclofen (Goldfrank’s 2015)

  • Inhibitory neurotransmitter that acts as a GABAB receptor agonist
  • Has both presynaptic and postsynaptic inhibitory properties
    • Presynaptic: prevents Ca2+ influx
    • Postsynaptic: increases K+ efflux
  • Inhibition results in decreased muscle tone and muscle spasms
  • Withdrawal likely results from loss of chronic inhibitory effect on postsynaptic receptors
  • Withdrawal typically occurs 24-48 hours after discontinuation of the drug or a reduction in dose

Intrathecal Baclofen PumpsBaclofen Pump

  • Catheter is placed into the cerebrospinal fluid (CSF) in the subarachnoid space
  • Catheter is connected to a pump which is typically inserted into the lower abdominal wall. This pump has a reservoir that can be filled with baclofen
  • Pump delivers baclofen in small amounts into the CSF causing inhibition at the spinal level

Causes of Baclofen Withdrawal (Stetkarova 2010)

  • Baclofen dose reduction
  • Intrathecal Pump Issues
    • Catheter dislodgement, kinking or migration
    • Reservoir underfilling: can occur if reservoir “missed” during medication refill leading to placement of medication in “pocket” around pump
    • Pump device malfunction

Presentation

  • Baclofen withdrawal mimics symptoms seen with other CNS depressant withdrawal syndromes
  • History
    • The patient may report a reduction in baclofen dose or cessation of the drug
    • Increased spasticity
    • Fever
    • Myalgias
    • Neuropsychiatric Symptoms: confusion, altered mental status, visual hallucinations
  • Physical Examination
    • Vital Sign Alterations
      • Hypertension
      • Tachycardia
      • Hyperthermia
    • Muscle rigidity
    • Seizures

Differential Diagnosis

  • Sepsis
  • Alcohol withdrawal
  • Benzodiazepine withdrawal
  • Serotonin syndrome

Note: Consider baclofen withdrawal in any patient who presents with vital sign abnormalities and has an intrathecal pump.


Diagnosticsbaclofenpump_ap

  • The diagnosis of baclofen withdrawal should be made on clinical grounds as there is no specific diagnostic test.
  • KUB X-ray
    • Used to visualize mechanical dysfunction – catheter dislodgment, kinking or migration
    • Will demonstrate spinal level of catheter
  • Pump interrogation
    • Typically performed by neurosurgery, interventional pain management or rehabilitation medicine
    • Will reveal if pump is malfunctioning or if reservoir needs to be refilled
  • Look for rhabdomyolysis
    • Increasing spasticity in withdrawal can cause muscle breakdown which can lead to renal dysfunction
    • Labs: Basic metabolic panel (for creatinine), urinalysis, creatinine kinase

Management

  • Initial supportive measures
    • Basics: IV, O2 (if hypoxic) and cardiac monitor
    • Fluid resuscitation
      • Patients have large insensible losses from fever, muscle spasm and increased respiratory rate
      • Start with 20-30 cc/kg and repeat as needed
    • Seizure management
      • Similarly, to alcohol withdrawal, seizures should be suppressed with CNS sedating agents and not typical antiepileptic drugs (i.e. phenytoin)
      • Benzodiazepines are the 1st line agents
    • Hyperthermia
      • Aggressive external cooling
      • Reasonable to administer antibiotics, obtain blood cultures and treat presumptively for infection as it can be difficult to differentiate hyperthermia from fever secondary to infection.
    • Rhabdomyolysis
      • Stop ongoing muscle destruction – relieve spasticity (see below), treat hyperthermia
      • Administer IV fluids to maintain kidney perfusion and urine output
      • Monitor patients for electrolyte abnormalities, particularly hyperkalemia
  • Directed medical management
    • Oral Baclofen is unlikely to be helpful in withdrawal because even with large doses, it is difficult to get adequate CSF levels
    • Intrathecal Baclofen
      • Optimal agent and route for treatment of baclofen withdrawal
      • Options for administration
        • Refill empty reservoir in functional pump without catheter obstruction
        • Administer via catheter side port if pump malfunctioning but catheter intact
        • Deliver via lumbar puncture (Shirley 2006)
    • Benzodiazepines
      • Treats withdrawal symptoms similarly to role in alcohol withdrawal
      • Expect that patient may require large doses to control symptoms
    • Propofol infusion
      • Consider starting infusion early in management prior to significant hemodynamic decompensation
      • Patient may require airway management with adequate propofol dose to manage withdrawal
    • Other
      • Numerous medications have been used in case reports and case series
      • Examples: Dantrolene, Tizanidine (Ross 2011)

Disposition

  • Balcofen withdrawal is a life-threatening syndrome and patients should be admitted to the ICU while arranging for definitive management
  • Pump or catheter malfunction typically requires neurosurgical intervention in the operating room
  • If an empty reservoir is identified and refilled, the patient may be able to be discharged if all signs and symptoms resolve

Take Home Points

  • Baclofen withdrawal from an intrathecal pump presents with hemodynamic instability, increased spasticity, fever and altered mental status. Consider the diagnosis in any patient with an intrathecal pump and the above symptoms.
  • Oral baclofen replacement is unlikely to treat the disorder as it does not achieve adequate CSF levels.
  • The optimal treatment for intrathecal baclofen withdrawal is administration of baclofen into the CSF but this can be technically difficult.
  • Treat baclofen withdrawal with escalating doses of benzodiazepines and consider propofol infusion for patients who continue to decline.

Read More:

  1. Rao R.B. (2015). Special Considerations. In Hoffman R.S., Howland M, Lewin N.A., Nelson L.S., Goldfrank L.R. (Eds), Goldfrank’s Toxicologic Emergencies, 10e. Link
  2. Chidester S, Smith S. Baclofen pump complications. The NYS Poison Centers Toxicology Letter 2011; 16(4): 1-12. Link

References:

  1. Hamilton R.J. (2015). Withdrawal Principles. In Hoffman R.S., Howland M, Lewin N.A., Nelson L.S., Goldfrank L.R. (Eds), Goldfrank’s Toxicologic Emergencies, 10e. Link
  2. Stetkarova I et al. Procedure- and device-related complications of intrathecal baclofen administration for management of adult muscle hypertonia: a review. Neurorehabil Neural Repair. 2010;24(7):609-619. PMID: 20233964
  3. Shirley KW et al. Intrathecal baclofen overdose and withdrawal. Pediatr Emerg Care. 2006;22(4):258-261. PMID: 16651918
  4. Ross J et al. Acute Intrathecal Baclofen Withdrawal: A Brief Review of Treatment Options. Neurocrit Care. 2011;14(1):103-108. PMID: 20717751

Post Peer Reviewed By: Salim Rezaie (Twitter: @srrezaie)

The following two tabs change content below.

Anand Swaminathan

Clinical Assistant Professor of Emergency Medicine at Bellvue/NYU
REBEL EM Associate Editor and Author

Latest posts by Anand Swaminathan (see all)

Tags: , , , ,
1 reply

Trackbacks & Pingbacks

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *

Time limit is exhausted. Please reload CAPTCHA.

Optimization WordPress Plugins & Solutions by W3 EDGE